Ada Health

Quick Verdict

Ada Health is best understood as a consumer symptom-assessment and health-information service, not an online doctor. Ada Assess asks about age, symptoms, timing, and related health factors, follows up with additional questions, and produces an informational report with possible related conditions and suggested next steps. That can make an unclear concern easier to describe to a clinician. It cannot confirm a diagnosis, examine the user, order a test, or prescribe treatment.

As of July 20, 2026, Ada’s official terms identify Ada Assess as a Class IIa medical device registered under EU Regulation 2017/745. This is a meaningful regulatory fact about a defined product and intended use in the European market. It is not evidence that every Ada page is a medical device, that the service has identical authorization worldwide, or that its output is equivalent to a physician’s judgment. Users and enterprise buyers must verify availability and regulatory status in the country where the product will actually be used.

Ada is not for emergencies. Chest pain, severe difficulty breathing, signs of stroke, loss of consciousness, a severe allergic reaction, heavy bleeding, suicidal intent, or any rapidly worsening and potentially life-threatening problem requires immediate contact with local emergency services. Do not wait for an assessment to finish. A licensed healthcare professional remains responsible for examination, diagnosis, medication, and treatment decisions.

Best For

Ada is a reasonable fit for adults and older teenagers who can describe a non-emergency concern and want to prepare for a consultation. Ada’s current terms require users to be at least 13, and users under 18 need consent from a legal guardian. It may also help someone record the timing and progression of symptoms before an appointment or read plain-language material from Ada’s medical library.

The service is a poor fit for anyone seeking certainty, a prescription, or permission to delay care. Children, pregnant people, immunocompromised users, people with multiple complex conditions, and anyone whose symptoms are changing quickly need especially cautious professional assessment because software cannot collect a full history or perform an examination. When one person enters information for another, they should have appropriate consent and must avoid guessing at material facts.

For organizations, Ada may serve as one component of a digital front door. It should only be deployed with a defined clinical pathway, regional regulatory review, privacy governance, escalation rules, and human accountability. A medical device classification does not transfer the duty of care from a provider to software.

Key Features

• Interactive symptom assessment: The questionnaire adapts to the answers supplied and turns them into a structured assessment report.
• Possible-condition information: Ada explains conditions that may be related to the reported findings. These are possibilities for discussion, not diagnoses.
• Next-step guidance: The report may indicate a general level of urgency or a type of care to consider. It does not perform a formal local triage or guarantee that deterioration will be detected.
• Medical library: Ada publishes health information created by doctors and grounded in research, covering conditions, symptoms, and general wellbeing.
• Reports and symptom records: Official terms state that users can generate assessment reports. Saving and sharing options can depend on the account, app version, region, or partner channel.
• Partner delivery: Ada Assess can be made available through partner websites and apps where offered. The partner experience may have separate terms, data flows, and onward-care options.
• Regional language options: Ada publishes in several languages, but language availability and localization are not uniform across every product surface or country.

The important design boundary is that these features organize information. They do not add physical examination, laboratory data, imaging, medication reconciliation, or direct observation of a sick person. The value of a report therefore depends heavily on accurate, complete input and appropriate follow-up.

Use Cases

One useful scenario is preparing for a routine visit. A user can document when a symptom started, what makes it better or worse, and what else occurred at the same time. The resulting report can prompt a more focused conversation, but the clinician should independently verify every material detail.

A second scenario is deciding what kind of non-emergency help to seek. Ada may help distinguish between continued observation, a routine appointment, and a need for quicker professional review. If the user’s condition feels more serious than the result suggests, the safer course is to seek human care. Persistent high fever, dehydration, severe pain, neurological changes, or repeated worsening should not be dismissed because of a reassuring screen.

Ada can also support general health education through its medical library. Reading is useful for learning vocabulary and preparing questions; it is not a basis for starting, stopping, or changing medication. In a partner deployment, an insurer or provider may use the assessment before directing a member to available care, but the organization remains responsible for the route, regional suitability, and clinical handoff.

Pricing

Ada’s current terms say that its website and Ada Assess are provided free of charge, with unlimited symptom assessments and assessment reports. The mobile health companion is also described as free to download. Features can still differ by operating system, country, account state, and partner channel. The consumer service does not include a physician consultation, prescription, laboratory test, emergency response, or guaranteed appointment.

Ada does not publish a universal price list for enterprise and partner deployments. Commercial pricing is therefore custom and should be confirmed directly for the intended region, volume, integration, support model, and regulated product configuration. Procurement teams should request clarity on service levels, data roles, incident handling, clinical escalation, device version, and termination or data-return terms rather than assuming that free consumer access makes commercial integration free.

Pros

• The core consumer assessment and reports are free under Ada’s current terms.
• A guided interview can produce a more organized symptom history than an unstructured web search.
• The service separates possible conditions and next-step information from a definitive diagnosis.
• Ada Assess has a clearly stated EU MDR Class IIa status for its defined intended use.
• The medical library provides a lower-risk way to learn terminology before speaking with a clinician.
• Partner delivery gives health organizations an integration route rather than forcing users into a separate generic search experience.
• Official terms explicitly describe the non-diagnostic and emergency limitations, making the intended boundary easier to evaluate.

Cons

• Output quality depends on the completeness and accuracy of user-entered information.
• Ada cannot perform a physical examination, take vital signs, review imaging, or order laboratory testing.
• App functions, languages, and onward-care links differ by country and distribution channel.
• EU medical-device registration does not automatically establish authorization in the United States, China, or any other region.
• Free use does not create a clinician relationship or include the cost of follow-up medical care.
• Sensitive symptom, medication, sexual-health, and demographic information creates a real privacy decision for users.
• A user may anchor on a listed possibility or underreact to deterioration, so human review remains essential.

Alternatives

Ada and Buoy are the closest options for a consumer who wants to organize symptoms without paying for a consultation. Infermedica and Healthily are more relevant to an organization building a governed digital front door. K Health is materially different because the paid service can connect eligible US users with licensed clinicians. Buyers should compare who carries clinical responsibility, where the service is authorized and available, and how urgent cases reach a human rather than comparing the products only by the presence of AI.

FAQ

Does Ada diagnose medical conditions?

No. Ada’s official terms state that Ada Assess and the website do not make medical diagnoses and do not prescribe treatment. A possible-condition list and next-step report are informational. Diagnosis requires a qualified healthcare professional who can review a complete history, examine the patient, and decide whether tests are needed.

Is Ada Assess a regulated medical device?

Ada identifies Ada Assess as a Class IIa medical device registered under the EU MDR. The statement applies to that product and intended use. It does not make every Ada article or partner service a device, and it should not be interpreted as authorization in every country.

Should I complete Ada before seeking help for chest pain or breathing difficulty?

No. Chest pain, severe breathing difficulty, stroke signs, loss of consciousness, severe allergic reaction, major bleeding, suicidal intent, or another potentially life-threatening problem requires immediate local emergency assistance. Ada is not an emergency dispatch service and cannot safely rule out every urgent condition.

How much does Ada cost for an individual?

Current official terms describe the website and Ada Assess as free and permit unlimited assessments and reports. That does not include physician visits, tests, medications, or third-party services. Enterprise and partner arrangements use custom commercial terms.

Can a user in China rely on the EU Class IIa status?

No. An EU classification does not establish Chinese regulatory authorization or local clinical suitability. A user may treat the report as a personal symptom record, but Chinese diagnosis, prescribing, and treatment decisions should remain within the local licensed healthcare system. Local app availability and Chinese-language support also need verification.

What privacy issues should I consider?

Ada says personal data is handled under applicable rules including GDPR and CCPA and provides a separate privacy policy. Users should still minimize unnecessary identifiers and protect their account. A partner-hosted version can involve additional data controllers or processors, so both Ada’s and the partner’s notices should be reviewed.

What if Ada’s result conflicts with my clinician’s advice or with how ill I feel?

Follow the licensed professional who has access to your actual history and accepts clinical responsibility, and disclose any change in symptoms. Do not cancel care, stop medication, or delay an appointment solely because an assessment appears reassuring. If symptoms worsen, seek prompt human review regardless of the earlier result.

Bottom Line

Ada Health is useful for turning a vague, non-emergency concern into a structured set of symptoms and questions. Its free consumer access and the EU MDR Class IIa status of Ada Assess are supportable facts, but neither makes the software a doctor or grants global authorization. Use it to prepare for care and learn terminology. Use local emergency services immediately for red flags. Leave examination, diagnosis, prescribing, and treatment to a licensed healthcare professional, and check regional availability, regulation, and privacy terms before relying on any partner deployment.